Product information and disease descriptionPlace of product in therapyApproaches to treatment
Heterogeneity of treatment effect
1 evidence topic · 2 sources
Treatment-by-subgroup interaction testing
No evidence found.
Bezuclastinib
Nonadvanced systemic mastocytosis
- Manufacturer
- Cogent Biosciences
- Regulatory submission
- NDA submitted December 2025
- Last updated